Drug intelligence / Profile preview

Oste Forte

Development stage: Unknown
Lead developer: SoHo Capital
Modality: Small Molecules
Administration: Oral

Overview

Oste Forte is an over-the-counter (OTC) health supplement developed and marketed by Soho Global Health in Indonesia. It is formulated to support joint health, maintain cartilage flexibility, and alleviate symptoms associated with osteoarthritis. The supplement contains a fixed-dose combination of active ingredients, including glucosamine hydrochloride, chondroitin sulfate, vitamin C (ascorbic acid), magnesium, zinc, and manganese. These components work synergistically to stimulate proteoglycan production, inhibit cartilage-degrading enzymes, promote collagen synthesis, and support overall connective tissue regeneration.

Brand names: Oste Forte
Other names: Oste Forte KapletOste Forte Tablet

Targets

LH (Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1)CD44 (CD44 antigen)P4H (Prolyl 4-hydroxylase subunit alpha-3)

Beyond the preview

Go deeper on Oste Forte.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oste Forte.

Explore the full profile